ABR-Affinity BioReagents Inks New Distribution Agreements in Switzerland and Hungary
redorbit.com     May 9, 2008            

DENVER and GOLDEN, Colo., May 9 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the finalization of new distribution agreements with LuBioScience GmbH, headquartered in Lucerne, Switzerland and Bio-Kasztel Ltd., located in Budapest, Hungary,... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Budapest: fine arts museum holds first-ever photography show (AFP)

yahoo.com     yesterday          

BUDAPEST (AFP) - Budapest's highbrow Museum of Fine Arts has staged its first-ever photography exhibition, causing a sensation with a novel show paying tribute to some of the best artists of the genre. Kertesz to Mapplethorpe...                

comments

                   

Walter "Tommy" Little left a comment for Kristin

tudiabetes.com     yesterday   9 related          

left a comment for Kristin 51 seconds ago Most recent A1C (BG Average) Value What glucose meter do you use? After a few years with an A1c between 7.2 and 8.2, and I've recently improved my control (mostly thanks to this...                

comments

TFN NEWS BRIEFING: TMT highlights to 15:40 BST (AFX)

yahoo.com     yesterday   1 related          

Hungarian digital TV licences go to France's TDF BUDAPEST (Thomson Financial) - A million Hungarian households will be able to receive eight to 10 digital radio and television channels instead of three analogue channels now,...                

comments

UK: Bernard Matthews to stop importing foreign turkeys

typepad.com     yesterday   2 related          

Via the Financial Times: Bernard Matthews halts sale of foreign-raised turkeys. Excerpt: Bernard Matthews Foods is to stop selling turkeys raised outside the UK, a move designed to address concerns that its outbreak of bird flu...                

comments